首页 | 本学科首页   官方微博 | 高级检索  
检索        

miR-361-5p通过靶向CCND1逆转胃癌SGC-7901细胞奥沙利铂耐药性
引用本文:齐雯丽,柯红,曾琼,周萍,万君,王磊.miR-361-5p通过靶向CCND1逆转胃癌SGC-7901细胞奥沙利铂耐药性[J].中国肿瘤生物治疗杂志,2021,28(4):346-352.
作者姓名:齐雯丽  柯红  曾琼  周萍  万君  王磊
作者单位:1. 三峡大学医学院 a. 2016级临床医学专业,b. 病原生物学部,湖北 宜昌 443002;2. 国药葛洲坝中心医院 a. 肿瘤科,b. 药学部,湖北 宜昌 443002
摘    要:目的:探讨miR-361-5p对胃癌SGC-7901细胞奥沙利铂(oxaliplatin,OXA)耐药性的影响及其作用机制.方法:采用qPCR法检测miR-361-5p在胃癌细胞MKN-45、MGC80-3、SGC-7901和OXA耐药细胞SGC-7901/OXA中的表达水平.利用脂质体转染技术分别将miR-361-5...

关 键 词:miR-361-5p  细胞周期蛋白1  胃癌  SGC-7901/OXA细胞  奥沙利铂  耐药
收稿时间:2020/10/22 0:00:00
修稿时间:2020/10/22 0:00:00

miR-361-5p reverses oxaliplatin resistance of gastric cancer SGC-7901 cells by targeting CCND1
QI Wenli,KE Hong,ZENG Qiong,ZHOU Ping,WAN Jun,WANG Lei.miR-361-5p reverses oxaliplatin resistance of gastric cancer SGC-7901 cells by targeting CCND1[J].Chinese Journal of Cancer Biotherapy,2021,28(4):346-352.
Authors:QI Wenli  KE Hong  ZENG Qiong  ZHOU Ping  WAN Jun  WANG Lei
Institution:1a. Clinical Medicine in Grade 2016, 1b. Department of Pathogenic Biology, Medical College of Three Gorges University, Yichang 443002, Hubei, China; 2a. Department of Oncology, 2b.Department of Pharmacy, Gezhouba Central Hospital of Sinopharm, Yichang 443002, Hubei, China
Abstract:Objective: To investigate the effects of miR-361-5p on the oxaliplatin (OXA) resistance of gastric cancer SGC-7901 cells and its mechanism. Methods: The expression of miR-361-5p in gastric cancer cells (MKN-45, MGC80-3 and SGC-7901) and drugresistant SGC-7901/OXA cells was detected by qPCR. The SGC-7901/OXA cells were transfected with miR-361-5p mimics/inhibitor or sh-CCND1 by using Liposome transfection technology. Then, cell proliferation, apoptosis and cell cycle of SGC-7901/OXA cells were measured by CCK-8 assay and Flow cytometry, respectively. The targeting relationship between miR-361-5p and CCND1 was examined by Dual luciferase report gene assay. The expression level of CCND1 in SGC-7901/OXA cells was detected by WB.Results: miR-361-5p was down-regulated in multiple gastric cancer cells and SGC-7901/OXA cells (P<0.05 or P<0.01). Over-expression of miR-361-5p significantly promoted the apoptosis, induced G0/G1 cell cycle arrest and inhibited cell proliferation of SGC-7901/OXA cells (P<0.05 or P<0.01). Dual luciferase reporter gene results verified that miR-361-5p targeted CCND1 and negatively regulated its expression (P<0.01). Further experiments showed that targeted down-regulation of CCND1 induced apoptosis and G0/G1 cell cycle arrest and inhibited CCND1 expression and proliferation of SGC-7901/OXA cells (P<0.05 or P<0.01). Over-expression of miR-361-5p targetedly down-regulated CCND1 and further promoted cell apoptosis, induced G0/G1 cell cycle arrest and inhibited cell proliferation of SGC-7901/OXA cells (P<0.05 or P<0.01). Conclusion: miR-361-5p over-expression can reverse the resistance of SGC-7901/OXA cells to OXA, and the mechanism may be related to its targeted down-regulation of CCND1 expression.
Keywords:miR-361-5p  cyclin D1 (CCND1)  gastric cancer  SGC-7901/OXA cell  oxaliplatin (OXA)  resistance
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号